Belgian health data Firm Cascador Health expands with key acquisitions in immunology and neurology.
Cascador Health, a Belgian company specializing in real-world healthcare data, has bolstered its European presence with the acquisitions of Galenus Health and Neuroventis. These strategic moves enhance Cascador’s capabilities in immunology and neurology, building on its established expertise in oncology.
The acquisitions give Cascador access to valuable data insights across the entire lifecycle of medical treatments, aiding pharmaceutical companies, physicians, and patients.
Galenus and Neuroventis bring with them extensive data platforms that provide critical insights into disease progression, particularly in immunology and neurology. Cascador’s CEO, Philip Taillieu, emphasized the company’s ambition to lead in Europe’s growing real-world evidence solutions market.
The global pharmaceuticals market is expected to grow to 1.36 trillion euros by 2029, with real-world data becoming increasingly crucial for innovation in key therapeutic areas.
Picture: Pixabay.com
